Text Version
Entrez PubMed Overview Help | FAQ Tutorial New/Noteworthy E-Utilities
PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher Clinical Queries LinkOut Cubby
Related Resources Order Documents NLM
Gateway TOXNET Consumer
Health Clinical Alerts ClinicalTrials.gov PubMed
Central
Privacy Policy
|
|
-
Bupropion-induced
somnambulism.
Khazaal Y, Krenz S, Zullino
DF.
Department Universitaire de Psychiatrie Adulte, Prilly,
Lausanne, Switzerland. Yasser.Khazaal@inst.hospvd.ch
Whereas
there are some case reports of bupropion-induced vivid dreaming and
nightmares, until now it has not been associated with somnambulism. A
case is reported of a patient treated with bupropion as a smoking
cessation medication, who developed somnambulism during nicotine
withdrawal. Furthermore, the sleepwalking episodes were associated with
eating behaviour. Amnesia was reported for all episodes. As, on one
hand,bupropion is a noradrenergic and dopaminergic drug and nicotine
withdrawal, on the other hand, is associated with alterations in
monoaminergic functions, an interaction at the level of these
neurotransmitters is suggested as the underlying
mechanism.
Publication Types:
PMID: 13129839 [PubMed - indexed for
MEDLINE]
|